Extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacteriaceae
- PMID: 30035710
- PMCID: PMC6113871
- DOI: 10.1099/mgen.0.000197
Extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacteriaceae
Erratum in
-
Corrigendum: Extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacteriaceae.Microb Genom. 2018 Sep;4(9):e000218. doi: 10.1099/mgen.0.000218. Microb Genom. 2018. PMID: 30265236 Free PMC article. No abstract available.
Abstract
Antimicrobial resistance (AMR) is a global public-health emergency, which threatens the advances made by modern medical care over the past century. The World Health Organization has recently published a global priority list of antibiotic-resistant bacteria, which includes extended-spectrum β-lactamase-producing Enterobacteriaceae and carbapenemase-producing Enterobacteriaceae. In this review, we highlight the mechanisms of resistance and the genomic epidemiology of these organisms, and the impact of AMR.
Keywords: CPE; ESBL; Enterobacteriaceae; Gram-negative; antimicrobial resistance.
Conflict of interest statement
The authors declare that there are no conflicts of interest.
Figures
References
-
- Tumbarello M, Spanu T, di Bidino R, Marchetti M, Ruggeri M, et al. Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-β-lactamase production and inadequate initial antibiotic therapy. Antimicrob Agents Chemother. 2010;54:4085–4091. doi: 10.1128/AAC.00143-10. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
